Mh. Samuels et al., EFFECTS OF NALOXONE INFUSIONS ON PULSATILE THYROTROPIN SECRETION, The Journal of clinical endocrinology and metabolism, 78(5), 1994, pp. 1249-1252
Endogenous opioids are known to modulate the secretion of some anterio
r pituitary hormones, but they are not thought to have significant eff
ects on TSH secretion. However, dynamic TSH secretion has not been cha
racterized during naloxone infusions. Therefore, we measured TSH level
s every 15 min over 24 h in nine healthy young men at baseline and dur
ing infusions of naloxone at 2 mg/h. A TRH test was performed after ea
ch study. TSH pulses were located by Cluster analysis. Naloxone infusi
ons decreased 24-h mean TSH levels by 28%, from 1.68 +/- 0.20 to 1.21
+/- 0.19 mU/L. Mean daytime TSH levels did not change, but nocturnal T
SH levels were decreased by 39%, from 2.21 +/- 0.30 to 1.35 +/- 0.21 m
U/L. There were no changes in TSH pulse frequency, but naloxone infusi
ons decreased 24-h TSH pulse amplitude by 32%, from 2.02 +/- 0.26 to 1
.37 +/- 0.21 mU/L. Daytime TSH pulse amplitude was relatively unaffect
ed (1.27 +/- 0.15 us. 1.16 +/- 0.21 mU/L), whereas nocturnal TSH pulse
amplitude was decreased by 42%, from 2.72 +/- 0.40 to 1.57 +/- 0.23 m
U/L. TSH responses to acute TRH administration were decreased after na
loxone infusions (12.38 +/- 1.93 us. 9.17 +/- 1.36 mU/L). Serum T-3 le
vels fell by 21% during naloxone infusions, from 1.9 +/- 0.1 to 1.5 +/
- 0.1 nmol/L, whereas other thyroid hormone levels and cortisol levels
were unchanged. These findings suggest that endogenous opioids have s
ignificant stimulatory effects on TSH secretion, predominantly during
the nocturnal TSH surge.